These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 14579500

  • 1. [To increase compliance-knowledge. Only every second schizophrenia patient remains faithful to the therapy].
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():108. PubMed ID: 14579500
    [No Abstract] [Full Text] [Related]

  • 2. [Longterm therapy of schizophrenia].
    Pajonk FG, Wobrock T, Falkai P.
    Fortschr Neurol Psychiatr; 2005 Mar 26; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C, Gourion D, Vaiva G.
    Encephale; 2009 Jan 26; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
    Benoit M, Pon J, Zimmermann MA.
    Encephale; 2009 Jan 26; Suppl 3():S87-90. PubMed ID: 19268184
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS, Stewart DW.
    J Psychopharmacol; 2006 Nov 26; 20(6 Suppl):20-37. PubMed ID: 17046985
    [Abstract] [Full Text] [Related]

  • 10. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM.
    J Clin Psychiatry; 2006 Nov 26; 67 Suppl 5():9-14. PubMed ID: 16822091
    [Abstract] [Full Text] [Related]

  • 11. New advances in pharmacotherapy for early psychosis.
    Emsley R.
    Early Interv Psychiatry; 2009 Sep 26; 3 Suppl 1():S8-12. PubMed ID: 21352195
    [Abstract] [Full Text] [Related]

  • 12. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR.
    J Clin Psychiatry; 2006 Sep 26; 67 Suppl 5():19-23. PubMed ID: 16822093
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P.
    J Psychopharmacol; 2006 Nov 26; 20(6 Suppl):38-56. PubMed ID: 17046986
    [Abstract] [Full Text] [Related]

  • 16. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
    Canceil O, Limosin F, Passerieux C.
    Encephale; 2009 Jan 26; Suppl 3():S101-7. PubMed ID: 19268178
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
    Kane JM.
    J Clin Psychiatry; 2003 Jan 26; 64 Suppl 16():34-40. PubMed ID: 14680417
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.